Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS)
Authors:
- 6 March 2014
- journal article
- other
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 171 (2) , 425-427
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS)Journal of Dermatological Science, 2013
- Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current conceptsAnais Brasileiros de Dermatologia, 2012
- The DRESS Syndrome: A Literature ReviewThe American Journal of Medicine, 2011
- Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndromeBritish Journal of Dermatology, 2007
- Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?British Journal of Dermatology, 2007
- Drug-induced Hypersensitivity Syndrome(DIHS): A Reaction Induced by a Complex Interplay among Herpesviruses and Antiviral and Antidrug Immune ResponsesAllergology International, 2006
- Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responsesImmunology Today, 1998
- The T Cell-directed CC Chemokine TARC Is a Highly Specific Biological Ligand for CC Chemokine Receptor 4Journal of Biological Chemistry, 1997